Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to asses the compared efficacy, safety and immunogenicity of
ENERCEPTAN® with ENBREL® in combination with Methotrexate for the treatment of patients with
rheumatoid arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
Gema Biotech S.A.
Collaborators:
QUID Quality in Drugs and Devices Latin American Consulting SRL QUID-Quality in Drugs and Devices Latin American Consulting SRL